Mergers and acquisitions in the medical device segment has been a bit sluggish this year. Even with two deals announced on September 1, marking 79th and 80th sector transactions in 2016, there is a lot of ground to make up to match the 114 deals announced in 2015.
Stryker Corporation (NYSE: SYK) announced its seventh acquisition this year, paying an undisclosed amount for Ivy Sports Medicine, LLC. Ivy Sports Medicine provides medicine therapies for orthopedic surgeons and patients through its comprehensive minimally invasive meniscal repair platform. It includes the only FDA-approved collagen meniscus implant (CMI®) on the market. Ivy’s history and sole focus on advancing the treatment of meniscal injuries is highly complementary to Stryker’s current portfolio of visualization, resection, fluid management and ACL reconstructive platforms.
That same day, Hocoma AG, a developer and manufacturer of automated therapy equipment for the rehabilitation of patients with neurological movement disorders, announced its merger with DIH International, a medical device company that self-develops dozens of products including upper-limb robotics and interactive rehab systems. The merger enables DIH to establish a global premiership in providing total solutions to customers with cutting edge technologies in robotics, virtual reality, sensing and automation.